Curaleaf (OTCMKTS:CURLF) Shares Gap Down – Here’s Why

Shares of Curaleaf Holdings, Inc. (OTCMKTS:CURLFGet Free Report) gapped down prior to trading on Tuesday . The stock had previously closed at $3.30, but opened at $3.00. Curaleaf shares last traded at $3.09, with a volume of 342,619 shares traded.

Analyst Upgrades and Downgrades

Separately, Cormark raised shares of Curaleaf from a “hold” rating to a “moderate buy” rating in a research report on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, According to MarketBeat.com, the stock presently has an average rating of “Strong Buy”.

Read Our Latest Stock Analysis on Curaleaf

Curaleaf Trading Down 9.8%

The firm has a market cap of $1.99 billion, a P/E ratio of -9.30 and a beta of 0.75. The company has a quick ratio of 0.70, a current ratio of 1.47 and a debt-to-equity ratio of 1.00. The firm’s 50-day simple moving average is $1.75 and its 200 day simple moving average is $1.22.

Curaleaf (OTCMKTS:CURLFGet Free Report) last posted its earnings results on Wednesday, August 6th. The company reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.01. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 14.61%. As a group, analysts expect that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current year.

About Curaleaf

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Read More

Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.